After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CRL belongs to the Healthcare sector of the NYSE while operating in the Diagnostics & Research industry. The current market capitalization of Charles River Laboratories International Inc is $8.54B. A total of 0.67 million shares were traded on the day, compared to an average of 1.13M shares.
In the most recent transaction, FOSTER JAMES C bought 6,075 shares of CRL for 165.01 per share on Feb 20 ’25. After the transaction, the Chairman, President and CEO now owns 183,639 company shares. In a previous transaction on Feb 20 ’25, Girshick Birgit bought 1,514 shares at 164.63 per share. CRL shares that Corporate Executive VP & COO owns now total 55,058.
Among the insiders who sold shares, LaPlume Joseph W disposed of 4,400 shares on Feb 20 ’25 at a per-share price of $162.50. This resulted in the EVP, Corp Strategy & Develop holding 20,013 shares of CRL after the transaction. In another insider transaction, Joseph LaPlume bought 4,400 shares at $165.00 per share on Feb 20 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CRL has a high of $274.77 and a low of $150.79.
As of this writing, CRL has an earnings estimate of $2.09 per share for the current quarter. EPS was calculated based on a consensus of 14.0 estimates, with a high estimate of $2.27 per share and a lower estimate of $2.01.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CRL’s latest balance sheet shows that the firm has $241.21M in Cash & Short Term Investments as of fiscal 2021. There were $2.92B in debt and $1.03B in liabilities at the time. Its Book Value Per Share was $67.69, while its Total Shareholder’s Equity was $2.59B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRL is Buy with a score of 3.24.
